Skip to main content

Table 1 Sensitivity analysis for the causal association between blood metabolites and epilepsy

From: Assessing the causal association between human blood metabolites and the risk of epilepsy

Metabolites

N

RAPS

WM

Egger

Heterogeneity

Pleiotropy

OR (95% CI)

P

OR (95% CI)

P

OR (95% CI)

P

Q (I2)

P

Intercept

P

Amino acid

 4-methyl-2-oxopentanoate

8

1.71 (1.06, 2.76)

0.03

1.73 (0.96, 3.09)

0.07

1.16 (0.17, 7.98)

0.88

4.59 (0%)

0.71

0.006

0.71

 Phenol sulfate

6

0.78 (0.63, 0.96)

0.02

0.85 (0.67, 1.09)

0.21

0.83 (0.45, 1.54)

0.59

6.24 (19.87%)

0.28

-0.003

0.84

Carbohydrate

 Lactate

6

0.59 (0.34, 0.99)

0.047

0.66 (0.34, 1.26)

0.21

0.33 (0.06, 1.72)

0.26

3.37 (0%)

0.64

0.01

0.51

 Bilirubin (Z,Z)

15

0.94 (0.87, 1.01)

0.08

0.97 (0.89, 1.05)

0.44

1.00 (0.88, 1.14)

0.95

16.4 (14.63%)

0.29

-0.006

0.23

 Threonate

8

1.44 (1.05, 1.97)

0.02

1.30 (0.89, 1.88)

0.17

1.11 (0.53, 2.36)

0.79

2.99 (0%)

0.89

0.006

0.51

Energy

 Phosphate

3

2.23 (0.94, 5.27)

0.07

2.37 (0.95, 5.88)

0.06

5.79 (0.31, 108.58)

0.45

0.49 (0%)

0.79

-0.01

0.63

Lipid

 1-myristoylglycerophosphocholine

4

0.75 (0.55, 1.02)

0.07

0.71 (0.50, 1.02)

0.06

0.58 (0.30, 1.15)

0.26

2.59 (0%)

0.46

0.009

0.5

 2-hydroxystearate

28

1.85 (1.29, 2.65)

0.001

1.58 (0.98, 2.53)

0.06

3.22 (0.96, 10.80)

0.07

34.0 (20.59%)

0.17

-0.006

0.33

 2-palmitoylglycerophosphocholine

22

1.27 (0.97, 1.67)

0.08

1.11 (0.80, 1.54)

0.55

1.06 (0.73, 1.54)

0.75

27.5 (23.64%)

0.15

0.005

0.21

 5alpha-androstan-3beta,17beta-diol disulfate

14

1.10 (0.99, 1.21)

0.07

1.07 (0.95, 1.21)

0.28

1.10 (0.93, 1.29)

0.28

11.8 (0%)

0.54

0.0001

0.98

 Decanoylcarnitine

15

0.80 (0.69, 0.94)

0.005

0.78 (0.65, 0.94)

0.01

0.75 (0.53, 1.05)

0.12

9.97 (0%)

0.76

0.003

0.64

 Myo-inositol

33

0.69 (0.53, 0.91)

0.008

0.67 (0.46, 0.96)

0.03

0.91 (0.52, 1.60)

0.75

30.7 (0%)

0.53

-0.003

0.43

 Palmitoleate (16:1n7)

7

1.37 (1.04, 1.80)

0.02

1.19 (0.83, 1.71)

0.34

1.20 (0.62, 2.32)

0.61

9.22 (34.92%)

0.16

0.005

0.61

Nucleotide

 Uridine

16

2.57 (1.55, 4.27)

0.0003

2.32 (1.19, 4.52)

0.01

3.83 (0.79, 18.59)

0.12

17.7 (15.25%)

0.28

-0.004

0.62

Peptide

 Gamma-glutamylphenylalanine

28

0.69 (0.50, 0.93)

0.02

0.60 (0.36, 0.98)

0.04

0.59 (0.35, 1.00)

0.06

34.2 (21.05%)

0.16

0.003

0.39

Xenobiotic

 Caffeine

9

1.09 (1.00, 1.19)

0.06

1.09 (0.98, 1.21)

0.12

1.02 (0.81, 1.29)

0.87

4.83 (0%)

0.77

0.005

0.58

 p-acetamidophenylglucuronide

25

0.99 (0.99, 1.00)

0.04

1.00 (0.99, 1.00)

0.22

1.00 (0.98, 1.01)

0.52

11.1 (0%)

0.99

-0.002

0.75

Unknown

 X-04495

10

0.66 (0.44, 0.97)

0.03

0.71 (0.42, 1.18)

0.18

5.98 (0.51, 70.7)

0.19

8.92 (0%)

0.44

-0.03

0.12

 X-06267

10

1.45 (1.01, 2.06)

0.04

1.41 (0.90, 2.22)

0.14

0.94 (0.40, 2.19)

0.88

12.0 (25.00%)

0.21

0.009

0.26

 X-11247

15

0.90 (0.81, 1.00)

0.05

0.93 (0.81, 1.06)

0.26

0.87 (0.68, 1.10)

0.27

11.9 (0%)

0.61

0.002

0.75

 X-11299

9

0.88 (0.77, 1.01)

0.07

0.93 (0.79, 1.11)

0.43

1.40 (0.62, 3.17)

0.44

8.85 (9.60%)

0.36

-0.02

0.29

 X-11374

13

0.85 (0.74, 0.98)

0.03

0.85 (0.72, 1.00)

0.05

0.62 (0.35, 1.08)

0.12

6.25 (0%)

0.9

0.01

0.25

 X-11847

11

1.13 (1.02, 1.25)

0.02

1.11 (0.97, 1.26)

0.13

1.23 (0.98, 1.55)

0.11

7.72 (0%)

0.66

-0.007

0.41

 X-12038

41

0.76 (0.57, 1.01)

0.06

0.83 (0.57, 1.22)

0.34

1.13 (0.22, 5.80)

0.89

32.8 (0%)

0.78

-0.004

0.63

 X-12093

14

0.92 (0.85, 1.00)

0.05

0.90 (0.81, 1.01)

0.08

0.94 (0.80, 1.10)

0.45

11.9 (0%)

0.54

-0.001

0.84

 X-12094

6

1.36 (1.00, 1.84)

0.047

1.51 (1.07, 2.14)

0.02

1.84 (0.81, 4.16)

0.22

2.57 (0%)

0.77

-0.008

0.48

 X-12749

37

0.71 (0.51, 0.97)

0.03

0.65 (0.44, 0.98)

0.04

0.41 (0.15, 1.10)

0.08

53.4 (32.58%)

0.03

0.006

0.25

 X-12844

12

0.74 (0.57, 0.98)

0.03

0.72 (0.51, 1.01)

0.06

0.42 (0.18, 0.98)

0.07

9.97 (0%)

0.53

0.01

0.18